Maxim Group analyst Naz Rahman maintained a Buy rating on NexGel Inc (NXGL – Research Report) yesterday and set a price target of $5.00. The company’s shares closed yesterday at $1.36.
According to TipRanks, Rahman is an analyst with an average return of -14.3% and a 33.64% success rate. Rahman covers the Healthcare sector, focusing on stocks such as Clene, scPharmaceuticals, and Neurosense Therapeutics Ltd..
NexGel Inc has an analyst consensus of Moderate Buy, with a price target consensus of $5.00.
See the top stocks recommended by analysts >>
The company has a one-year high of $2.04 and a one-year low of $1.09. Currently, NexGel Inc has an average volume of 19.16K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
NexGel Inc is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics.
Read More on NXGL:
- NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results
- Nexgel, Inc. (NXGL) Q4 Earnings Cheat Sheet
- NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th
- NexGel partners with former MLL player Greg Gurenlian
- NEXGEL Partners with Former Major League Lacrosse Player, Greg “The Beast” Gurenlian, and The Face-Off Academy to Fight Turf Burn with Turfguard
